|
市場調査レポート
商品コード
1058848
粘液除去装置の世界市場(2021年~2028年)Global Mucus Clearance Devices Market - 2021-2028 |
||||||
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。 |
粘液除去装置の世界市場(2021年~2028年) |
出版日: 2022年02月16日
発行: DataM Intelligence
ページ情報: 英文 175 Pages
納期: 約2営業日
|
当レポートでは、世界の粘液除去装置市場について調査分析し、市場力学、業界分析、市場分析、競合情勢など、体系的な情報を提供しています。
The Global "Mucus Clearance Devices Market" is Predicted to reach at a CAGR of 6.1% during the forecast period (2021-2028).
The self-cleaning mechanism of the airways in the respiratory system is referred to as mucus clearance (MCC), mucociliary transport, or the mucociliary escalator. It is the protective process for the lungs that remove inhaled particles, including pathogens before they reach the sensitive tissue of the lungs. Mucus clearance devices are tools that aid in removing mucus from airway. These devices are used in respiratory therapy procedures to help with mucus expulsion. PEP Devices, OPEP Devices, and HFCWO are examples of Mucus Clearance Devices.
The global mucus clearance devices market growth is driven by increasing instances of asthma and COPD cases across the globe, favorable reimbursement polices and increase in government funding in healthcare sectors.
The increase in prevalance of asthma and COPD cases in the market will drive the market growth
The mucus clearance devices market growth is driven by rising prevalence of chronic obstructive pulmonary disease (COPD) and asthma. Asthma is a respiratory condition in which mucus production, inflammation, and muscle tension obstruct the lungs' airways. Similarly, Chronic Obstructive Pulmonary Disease (COPD) is caused by a blockage in the airways, leading to difficulty breathing, and is caused by cigarette smoking as the primary reason.
Asthma is ranked 16th among the leading causes of years lived with disability and 28th among the leading causes of disease burden, as defined by disability-adjusted life years, according to the 2018 Global Asthma Report published by the GAN Global Centre in Auckland, New Zealand. Around 300 million people worldwide have asthma, with an additional 100 million expected by 2025. According to the CDC, 9 million adults were diagnosed with chronic bronchitis in 2018, which leads to increased demand for mucus clearance devices, thereby fueling the market.
Asthma prevalence, severity, and mortality vary greatly across the country. While asthma is more common in high-income nations, most asthma-related deaths occur in low- and middle-income countries. This contributes to the growth of the global mucus clearance devices market.
High cost of mucus clearance devices is likely to hamper the market growth
High cost of treatment is the major drawback which is likely to hamper the market . Majority of under developed and developing countries are facing this problem due to less share from the government sector. In less developed countries, a lack of cost-effective drugs has influenced population health and resulted in a low average life expectancy.
COVID-19 has a serious impact on the mucus clearance devices market growth. The manufacturing and selling were severely affected during the lockdown, and the major companies were imposed with several restrictions. The manufacturing of the devices came to a halt, and the companies faced major losses.
The PEP and OPEP device segment is expected to grow at the fastest CAGR during the forecast period (2021-2028)
Mucus clearance devices are medically required to treat COPD, cystic fibrosis, bronchiectasis, and asthma. The rise in the number of requests for PEP machines to be transported internationally boosts the global mucus clearance device market. Positive expiratory pressure (PEP) is a small device into which a patient exhales through a mask. PEP is also known as PEP Therapy, PEP Mask, and TheraPEP. PEP is the required standard therapy, and when used as directed, it provides significant health benefits while OPEP devices are designed to disrupt expiratory airflow by providing resistance during exhalation, causing the airways to vibrate and loosen the mucus.
Furthermore, introducing a few mucus clearance devices, such as Aerobika, The Lung Flute, Flutter, Acapella, and others, has accelerated the market. This has increased the popularity of PEP and OPEP devices, which is expected to drive revenue growth in the mucus clearance devices market over the forecast period.
North America region holds the largest market share of global mucus clearance devices market
North America region holds the largest market share owing to the factor such increasing instances of asthma and COPD cases. As per Centers for Disease Control and Prevention (CDC), in a report (2019), stated that asthma affects one out of thirteen persons. Asthma affects more than 25 million people in the United States, equating to 7.7% of adults and 8.4% of children. Asthma has been on the rise in all ages, sex, and racial groups since the early 1980s. 8.3 per cent of children in the United States had asthma in 2016, according to the American Academy of Allergy Asthma and Immunology. Boys were slightly more likely than girls to have asthma, with 9.2 per cent and 7.4 per cent, respectively.
North America is expected to drive the global mucus clearance devices market. The respective FDAs in China and the United States encourage a strong trend of innovation in the pharmaceutical industry in both of these regions. This includes, among other things, streamlining approval processes and encouraging trial norms. Many innovations and subsequent approvals have resulted from the encouragement. Rising innovation increased funding for new devices, and an increase in chronic respiratory illnesses are expected to propel the mucus clearance devices market in the forecast period.
The mucus clearance devices market is highly competitive with presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Hill Rom Services Inc, Allergan, Koninklijke Philips N.V., Smiths Medical, Electromed Inc, Philips, Monaghan Medical Corporation, Respiratory Technologies Inc, Thayer Medical Corporation, VORTRAN Medical, PARI Medical Holding GmbH, Medical Acoustics, LLC,R.Cegia GmbH&Co.KG, International Biophysics Corporation, Westmed Inc, D.R. BURTON HEALTHCARE, Electromed Inc. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the rare disease genetic testing market globally.
Allergan PLC
Overview: Allergan plc is a pharmaceutical company based in the United States with an Irish headquarters that acquires, develops, manufactures, and markets brand-name drugs and medical devices in medical aesthetics, eye care, central nervous system, gastroenterology etc.
Flutter: The Flutter is a fist-sized mucus clearance device that allows patients to clear excess secretions from their lungs regardless of where they are. The Flutter device does not require batteries and is simple to clean to ensure hygiene.
Visualize the composition of the global mucus clearance devices market segmentation by product type, indication, end user, and region highlighting the key commercial assets and players.
Identify commercial opportunities in global mucus clearance devices market by analyzing trends and co-development deals.
Excel data sheet with thousands of data points of global mucus clearance devices market- level 4/5 segmentation.
PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
Product mapping in excel for the key product of all major market players
The global mucus clearance devices market report would provide an access to an approximately 40+ market data table, 45+ figures and 180 pages.
Service Providers/ Buyers
Industry Investors/Investment Bankers
Education & Research Institutes
Research Professionals
Emerging Companies
Manufacturers
Global Mucus Clearance Devices market- By Product Type
HFCWO Devices
OPEP Devices
MCA Devices
IPV Devices
PEP Devices
Others
Global Mucus Clearance Devices market- By Indication
COPD
Asthma
Cystic Fibrosis
Bronchiectasis
Others
Global Mucus Clearance Devices market- By End User
Hospitals
Home care settings
Clinics
Others
Global Mucus Clearance Devices market- By Region
North America
Europe
Asia-Pacific
Middle East & Africa
South America
LIST NOT EXHAUSTIVE